Search Results 301-310 of 17148 for monoclonal antibody

  1. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. PURPOSE: This phase I/II trial is studying the side effects and best ...

  2. Nivolumab and hyaluronidase-nvhy (subcutaneous route) - Side effects & uses - Mayo Clinic

    Nivolumab is a monoclonal antibody that affects the immune system and helps control the growth of cancer cells. This medicine is to be given only by or ...

  3. Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery - Mayo Clinic

    Cryosurgery, also known as cryoablation or cryotherapy, kills tumor cells by freezing them. Monoclonal antibodies, such as pembrolizumab, may block tumor growth ...

  4. Trastuzumab-strf (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-strf is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  5. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help ... monoclonal antibody including nivolumab and/or any of its excipients. Severe ...

  6. Asher A. Chanan-Khan, M.D. - Mayo Clinic Faculty Profiles

    Monoclonal antibody therapies in multiple myeloma. Preclinical models of Waldenstrom macroglobulinemia. Significance to Patient Care. Dr. Chanan-Khan is ...

  7. Dostarlimab-gxly (intravenous route) - Side effects & uses - Mayo Clinic

    Dostarlimab-gxly is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  8. Breast Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as atezolizumab, may block tumor growth in ... Denosumab is a monoclonal antibody that is used to treat bone loss in order ...

  9. Talquetamab-tgvs (subcutaneous route) - Side effects & uses - Mayo Clinic

    These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

  10. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...